{"hands_on_practices": [{"introduction": "Gene expression is a stochastic process, with promoters switching between 'on' and 'off' states at rates $k_{\\mathrm{on}}$ and $k_{\\mathrm{off}}$. This exercise uses the classic two-state model to quantify how epigenetic modifications, a central theme in cancer, can alter these kinetics. By modeling the effects of promoter hypermethylation on $k_{\\mathrm{on}}$, $k_{\\mathrm{off}}$, and the transcription rate $r$, you will gain a concrete understanding of how cancer cells silence tumor-suppressor genes [@problem_id:2622972].", "problem": "A diploid somatic cell expresses a tumor-suppressor gene from the maternal allele, while the paternal allele is silenced by allele-specific DNA methylation established during gametogenesis and maintained during early embryogenesis, a phenomenon known as genomic imprinting. Briefly explain, in words, how cytosine DNA methylation at CpG dinucleotides contributes to parent-of-origin-specific silencing (genomic imprinting) and to developmental timing of gene expression. Then, quantify how cancer-associated promoter hypermethylation alters the effective transcription rate of the maternal allele using a stochastic two-state promoter model.\n\nAssume the following biologically grounded modeling framework and parameters:\n- The promoter switches between an off state and an on state with transition rates $k_{\\mathrm{on}}$ (off to on) and $k_{\\mathrm{off}}$ (on to off), respectively, both in $\\mathrm{h}^{-1}$. When in the on state, RNA polymerase II initiates transcripts at rate $r$ in $\\mathrm{h}^{-1}$. The paternal allele remains silenced on the relevant timescale due to imprinting, so its contribution is negligible.\n- In the unmethylated baseline for the maternal allele, the rates are $k_{\\mathrm{on}} = 0.5\\,\\mathrm{h}^{-1}$, $k_{\\mathrm{off}} = 1.0\\,\\mathrm{h}^{-1}$, and $r = 20\\,\\mathrm{h}^{-1}$.\n- In the hypermethylated cancer state, methyl-CpG binding and associated chromatin compaction reduce promoter accessibility and initiation, such that $k_{\\mathrm{on}}$ is divided by $10$, $k_{\\mathrm{off}}$ is multiplied by $2$, and $r$ is multiplied by $0.7$.\n\nStarting from the master equation for the two-state promoter and standard steady-state reasoning for a continuous-time Markov process, derive the steady-state fraction of time the promoter is in the on state and use it to obtain the effective mean transcription initiation flux per allele. Compute the fold-change (hypermethylated divided by baseline) in the effective transcription rate of the maternal allele under the given parameter changes. Express your final fold-change as a pure decimal number rounded to four significant figures (no units).", "solution": "The problem presented is scientifically grounded, well-posed, and contains all necessary information for a complete solution. It consists of a qualitative explanatory component and a quantitative modeling component, both of which are standard exercises in molecular and systems biology. I will therefore proceed with a full solution.\n\nFirst, we address the qualitative explanation of DNA methylation's role.\nCytosine DNA methylation at CpG dinucleotides is a fundamental epigenetic mechanism regulating gene expression. Its role in genomic imprinting and developmental timing is as follows:\n$1$. **Parent-of-origin-specific silencing (Genomic Imprinting):** During gametogenesis (the formation of sperm and oocytes), specific sets of genes are marked by DNA methylation in a sex-dependent manner. For a given imprinted gene, the allele from one parent (e.g., paternal) is methylated at its promoter or associated regulatory regions, while the allele from the other parent (maternal) remains unmethylated. These methylation marks are heritable through mitosis after fertilization and are maintained in the somatic cells of the developing embryo. The mechanism of silencing involves two primary processes. First, the methyl group in the major groove of the DNA can directly block the binding of sequence-specific transcription factors, preventing the assembly of the pre-initiation complex. Second, and more pervasively, methylated CpG sites are recognized and bound by specific proteins known as methyl-CpG-binding domain (MBD) proteins. These MBD proteins, in turn, recruit larger repressive complexes, including histone deacetylases (HDACs) and histone methyltransferases (HMTs), which modify the local chromatin structure. This leads to the deacetylation and methylation of histone tails, resulting in a compact, transcriptionally inert chromatin state (heterochromatin), which physically obstructs access of the entire transcriptional machinery to the gene. This ensures that only one parental allele is expressed, a phenomenon critical for normal development.\n\n$2$. **Developmental timing of gene expression:** DNA methylation patterns are not static but are dynamically regulated during cellular differentiation and development. A key example is the global demethylation that occurs in the early embryo, followed by de novo methylation that establishes lineage-specific expression patterns. Genes required only at specific developmental stages or in particular cell types can be kept silent by DNA methylation and then activated by targeted demethylation. This process acts as a form of cellular memory and a molecular clock, ensuring that gene expression programs are executed with precise temporal and spatial control. For instance, pluripotency genes are active in embryonic stem cells but are silenced via DNA methylation as cells commit to specific fates.\n\nNext, we address the quantitative part of the problem. We are asked to quantify the change in transcription rate for a tumor-suppressor gene on the maternal allele, which becomes hypermethylated in a cancer state. We use a stochastic two-state promoter model.\n\nLet the promoter state be a random variable that can be either 'on' or 'off'. Let $P_{\\mathrm{on}}(t)$ and $P_{\\mathrm{off}}(t)$ be the probabilities of being in the 'on' and 'off' states at time $t$, respectively. The transitions between states are governed by a continuous-time Markov process with rates $k_{\\mathrm{on}}$ (for off $\\to$ on) and $k_{\\mathrm{off}}$ (for on $\\to$ off). The system must satisfy the conservation of probability:\n$$ P_{\\mathrm{on}}(t) + P_{\\mathrm{off}}(t) = 1 $$\nThe time evolution of the probabilities is described by the master equation:\n$$ \\frac{d P_{\\mathrm{on}}}{dt} = k_{\\mathrm{on}} P_{\\mathrm{off}} - k_{\\mathrm{off}} P_{\\mathrm{on}} $$\nAt steady state, the probabilities are constant, so $\\frac{d P_{\\mathrm{on}}}{dt} = 0$. Let $P_{\\mathrm{on}}^{ss}$ and $P_{\\mathrm{off}}^{ss}$ denote the steady-state probabilities. The master equation becomes:\n$$ k_{\\mathrm{on}} P_{\\mathrm{off}}^{ss} = k_{\\mathrm{off}} P_{\\mathrm{on}}^{ss} $$\nUsing the conservation relation $P_{\\mathrm{off}}^{ss} = 1 - P_{\\mathrm{on}}^{ss}$, we substitute and solve for $P_{\\mathrm{on}}^{ss}$:\n$$ k_{\\mathrm{on}} (1 - P_{\\mathrm{on}}^{ss}) = k_{\\mathrm{off}} P_{\\mathrm{on}}^{ss} $$\n$$ k_{\\mathrm{on}} - k_{\\mathrm{on}} P_{\\mathrm{on}}^{ss} = k_{\\mathrm{off}} P_{\\mathrm{on}}^{ss} $$\n$$ k_{\\mathrm{on}} = (k_{\\mathrm{on}} + k_{\\mathrm{off}}) P_{\\mathrm{on}}^{ss} $$\nThis gives the steady-state fraction of time the promoter is in the 'on' state:\n$$ P_{\\mathrm{on}}^{ss} = \\frac{k_{\\mathrm{on}}}{k_{\\mathrm{on}} + k_{\\mathrm{off}}} $$\nThe problem defines an effective mean transcription initiation flux, which we denote as $\\Phi$. This is the product of the transcription rate when the promoter is 'on', $r$, and the probability of the promoter being in the 'on' state:\n$$ \\Phi = r \\times P_{\\mathrm{on}}^{ss} = r \\frac{k_{\\mathrm{on}}}{k_{\\mathrm{on}} + k_{\\mathrm{off}}} $$\nWe now apply this formula to the two specified conditions: baseline (B) and hypermethylated (H).\n\nFor the baseline case, the parameters are $k_{\\mathrm{on}, B} = 0.5\\,\\mathrm{h}^{-1}$, $k_{\\mathrm{off}, B} = 1.0\\,\\mathrm{h}^{-1}$, and $r_B = 20\\,\\mathrm{h}^{-1}$. The baseline flux is:\n$$ \\Phi_B = r_B \\frac{k_{\\mathrm{on}, B}}{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}} $$\nFor the hypermethylated cancer state, the parameters are altered:\n$k_{\\mathrm{on}, H} = k_{\\mathrm{on}, B} / 10$\n$k_{\\mathrm{off}, H} = k_{\\mathrm{off}, B} \\times 2$\n$r_H = r_B \\times 0.7$\nThe flux in the hypermethylated state is:\n$$ \\Phi_H = r_H \\frac{k_{\\mathrm{on}, H}}{k_{\\mathrm{on}, H} + k_{\\mathrm{off}, H}} $$\nWe are required to compute the fold-change, $F$, defined as the ratio of the hypermethylated flux to the baseline flux:\n$$ F = \\frac{\\Phi_H}{\\Phi_B} = \\frac{r_H \\frac{k_{\\mathrm{on}, H}}{k_{\\mathrm{on}, H} + k_{\\mathrm{off}, H}}}{r_B \\frac{k_{\\mathrm{on}, B}}{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}} $$\nSubstitute the relationships between the parameters:\n$$ F = \\frac{(0.7 r_B) \\frac{k_{\\mathrm{on}, B} / 10}{(k_{\\mathrm{on}, B} / 10) + (2 k_{\\mathrm{off}, B})}}{r_B \\frac{k_{\\mathrm{on}, B}}{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}} $$\nThe term $r_B$ cancels out. We rearrange the expression:\n$$ F = 0.7 \\times \\left( \\frac{k_{\\mathrm{on}, B} / 10}{k_{\\mathrm{on}, B} / 10 + 2 k_{\\mathrm{off}, B}} \\right) \\times \\left( \\frac{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}{k_{\\mathrm{on}, B}} \\right) $$\nSimplify by canceling $k_{\\mathrm{on}, B}$ from the numerator of the second fraction and the denominator of the first (after factoring):\n$$ F = 0.7 \\times \\left( \\frac{1}{10} \\frac{k_{\\mathrm{on}, B}}{k_{\\mathrm{on}, B} / 10 + 2 k_{\\mathrm{off}, B}} \\right) \\times \\left( \\frac{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}{k_{\\mathrm{on}, B}} \\right) = 0.7 \\times \\frac{1}{10} \\times \\frac{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}{k_{\\mathrm{on}, B} / 10 + 2 k_{\\mathrm{off}, B}} $$\nMultiply the numerator and denominator of the fraction by $10$ to clear the denominator:\n$$ F = 0.7 \\times \\frac{k_{\\mathrm{on}, B} + k_{\\mathrm{off}, B}}{k_{\\mathrm{on}, B} + 20 k_{\\mathrm{off}, B}} $$\nNow, we substitute the numerical values for the baseline parameters, $k_{\\mathrm{on}, B} = 0.5$ and $k_{\\mathrm{off}, B} = 1.0$:\n$$ F = 0.7 \\times \\frac{0.5 + 1.0}{0.5 + 20(1.0)} $$\n$$ F = 0.7 \\times \\frac{1.5}{20.5} $$\n$$ F = \\frac{1.05}{20.5} $$\n$$ F \\approx 0.051219512... $$\nRounding to four significant figures as required, we obtain:\n$$ F \\approx 0.05122 $$\nThis result indicates that promoter hypermethylation leads to a dramatic reduction in the effective transcription rate to approximately $5.122\\%$ of its baseline level for the maternal allele.", "answer": "$$\n\\boxed{0.05122}\n$$", "id": "2622972"}, {"introduction": "Stable cell fates are often governed by gene regulatory circuits with feedback. This practice explores the classic mutual-inhibition toggle switch, described by a system of nonlinear ODEs, which is a core motif driving processes like the Epithelial-Mesenchymal Transition (EMT). You will perform a stability analysis to find the critical production rate $\\alpha_c$ at which the system bifurcates, creating bistability, as a function of the repressive cooperativity $n$ [@problem_id:2623008].", "problem": "Consider a coarse-grained dynamical system modeling a double-negative feedback between an epithelial transcriptional program and a mesenchymal transcriptional program during epithelial–mesenchymal transition (EMT) in carcinoma. Let $x$ denote the activity of an epithelial determinant and $y$ denote the activity of a mesenchymal determinant (for example, an EMT transcription factor (TF)). Each program represses the other’s production through cooperative binding described by Hill repression. A widely used dimensionless form of such a mutual-inhibition toggle is\n$$\n\\frac{dx}{dt} \\;=\\; \\frac{\\alpha}{1+y^{n}} \\;-\\; x,\\qquad\n\\frac{dy}{dt} \\;=\\; \\frac{\\alpha}{1+x^{n}} \\;-\\; y,\n$$\nwhere $\\alpha>0$ is a tunable effective production parameter (absorbing synthesis and degradation scales) and $n>0$ is the Hill coefficient representing the cooperativity of repression. Biological observations in developmental biology show that double-negative feedback with sufficient nonlinearity can generate bistability, enabling alternative stable cell-fate attractors.\n\nStarting only from the standard properties of Hill repression and the local linear stability criterion for ordinary differential equations (the steady state is locally stable if and only if all eigenvalues of the Jacobian have negative real parts), analytically determine the exact critical value $\\alpha_{c}(n)$ at which the symmetric steady state $x=y$ loses stability via a bifurcation (signaling the onset of bistability) as a function of the Hill coefficient $n$ with $n>1$. Express your final answer as a single closed-form expression in terms of $n$. Do not provide an inequality; provide only the expression for $\\alpha_{c}(n)$.\n\nIn a brief justification within your derivation, connect this threshold to how overexpression of EMT TFs in carcinoma cells can shift the system from an epithelial attractor to a mesenchymal attractor by effectively moving parameters across this stability boundary. Your final answer must be an exact expression; no numerical rounding is required.", "solution": "The problem presented is a valid exercise in nonlinear dynamics and bifurcation theory, applied to a canonical model of cell-fate switching in developmental and cancer biology. It is scientifically grounded, well-posed, and contains all necessary information for an analytical solution. We will now proceed with the derivation.\n\nThe dynamical system is given by the following coupled ordinary differential equations:\n$$\n\\frac{dx}{dt} = \\frac{\\alpha}{1+y^{n}} - x\n$$\n$$\n\\frac{dy}{dt} = \\frac{\\alpha}{1+x^{n}} - y\n$$\nHere, $x$ and $y$ represent the activities of epithelial and mesenchymal transcriptional programs, respectively. The parameter $\\alpha > 0$ is the effective production rate, and $n > 1$ is the Hill coefficient for the repressive interactions.\n\nFirst, we identify the symmetric steady state of the system, where $\\frac{dx}{dt} = 0$, $\\frac{dy}{dt} = 0$, and $x=y$. Let us denote this steady-state concentration as $x^*$, such that the steady state is $(x^*, x^*)$. Substituting these conditions into the equations, we obtain a single equation for $x^*$:\n$$\nx^* = \\frac{\\alpha}{1+(x^*)^{n}}\n$$\nThis can be rearranged to express $\\alpha$ as a function of $x^*$:\n$$\n\\alpha = x^*(1 + (x^*)^{n}) = x^* + (x^*)^{n+1}\n$$\nThis equation relates the steady-state value $x^*$ to the system parameter $\\alpha$.\n\nNext, we analyze the local stability of this symmetric steady state. Stability is determined by the eigenvalues of the Jacobian matrix, $J$, evaluated at the steady state. The generic Jacobian for this system is:\n$$\nJ(x,y) = \\begin{pmatrix} \\frac{\\partial}{\\partial x}\\left(\\frac{\\alpha}{1+y^{n}} - x\\right) & \\frac{\\partial}{\\partial y}\\left(\\frac{\\alpha}{1+y^{n}} - x\\right) \\\\ \\frac{\\partial}{\\partial x}\\left(\\frac{\\alpha}{1+x^{n}} - y\\right) & \\frac{\\partial}{\\partial y}\\left(\\frac{\\alpha}{1+x^{n}} - y\\right) \\end{pmatrix} = \\begin{pmatrix} -1 & -\\frac{\\alpha n y^{n-1}}{(1+y^n)^2} \\\\ -\\frac{\\alpha n x^{n-1}}{(1+x^n)^2} & -1 \\end{pmatrix}\n$$\nWe evaluate this matrix at the symmetric steady state $(x^*, x^*)$:\n$$\nJ(x^*,x^*) = \\begin{pmatrix} -1 & -\\frac{\\alpha n (x^*)^{n-1}}{(1+(x^*)^n)^2} \\\\ -\\frac{\\alpha n (x^*)^{n-1}}{(1+(x^*)^n)^2} & -1 \\end{pmatrix}\n$$\nLet us define the off-diagonal term as $A = \\frac{\\alpha n (x^*)^{n-1}}{(1+(x^*)^n)^2}$. The Jacobian simplifies to:\n$$\nJ^* = \\begin{pmatrix} -1 & -A \\\\ -A & -1 \\end{pmatrix}\n$$\nThe eigenvalues $\\lambda$ are the roots of the characteristic equation $\\det(J^* - \\lambda I) = 0$:\n$$\n\\det \\begin{pmatrix} -1-\\lambda & -A \\\\ -A & -1-\\lambda \\end{pmatrix} = (-1-\\lambda)^2 - (-A)^2 = (1+\\lambda)^2 - A^2 = 0\n$$\nThis gives $(1+\\lambda) = \\pm A$, leading to the two eigenvalues:\n$$\n\\lambda_1 = A - 1\n$$\n$$\n\\lambda_2 = -A - 1\n$$\nAccording to the stability criterion provided, the steady state is locally stable if and only if the real parts of all eigenvalues are negative. Since $\\alpha > 0$, $n > 1$, and $x^*$ must be positive for a biologically meaningful steady state, the term $A$ is strictly positive. Consequently, the eigenvalue $\\lambda_2 = -A-1$ is always negative. The stability of the symmetric state is therefore determined entirely by the sign of $\\lambda_1 = A-1$. The state is stable if $\\lambda_1 < 0$ (i.e., $A < 1$) and unstable if $\\lambda_1 > 0$ (i.e., $A > 1$).\n\nA bifurcation, signaling the loss of stability, occurs precisely when an eigenvalue crosses the imaginary axis. For this system, this happens when $\\lambda_1 = 0$. This defines the critical condition for the onset of bistability:\n$$\nA = 1 \\implies \\frac{\\alpha n (x^*)^{n-1}}{(1+(x^*)^n)^2} = 1\n$$\nThis condition, along with the steady-state equation, defines the bifurcation point. We now have a system of two equations for the critical parameter value $\\alpha_c$ and the corresponding steady-state value $x^*_c$:\n1. From the steady state: $\\alpha_c = x^*_c(1 + (x^*_c)^{n})$\n2. From the bifurcation condition: $\\alpha_c n (x^*_c)^{n-1} = (1+(x^*_c)^n)^2$\n\nWe solve this system to find $\\alpha_c$ as a function of $n$. From the steady-state equation, we have $1+(x^*_c)^n = \\alpha_c/x^*_c$. Substituting this into the bifurcation equation gives:\n$$\n\\alpha_c n (x^*_c)^{n-1} = \\left(\\frac{\\alpha_c}{x^*_c}\\right)^2 = \\frac{\\alpha_c^2}{(x^*_c)^2}\n$$\nSince $\\alpha_c > 0$ for a non-trivial system, we can divide by $\\alpha_c$:\n$$\nn (x^*_c)^{n-1} = \\frac{\\alpha_c}{(x^*_c)^2} \\implies \\alpha_c = n (x^*_c)^{n+1}\n$$\nNow we have two expressions for $\\alpha_c$:\n$$\nn (x^*_c)^{n+1} = x^*_c + (x^*_c)^{n+1}\n$$\nRearranging to solve for $x^*_c$:\n$$\n(n-1)(x^*_c)^{n+1} = x^*_c\n$$\nSince the trivial state $x^*_c=0$ is not of interest (it is stable but corresponds to extinction), we can divide by $x^*_c$ (assuming $x^*_c \\neq 0$):\n$$\n(n-1)(x^*_c)^n = 1 \\implies (x^*_c)^n = \\frac{1}{n-1}\n$$\nThis requires $n > 1$, which is consistent with the problem statement. From this, we find the steady-state concentration at the bifurcation point:\n$$\nx^*_c = \\left(\\frac{1}{n-1}\\right)^{1/n} = (n-1)^{-1/n}\n$$\nFinally, we substitute this value of $x^*_c$ back into the expression $\\alpha_c = n (x^*_c)^{n+1}$ to find the critical value $\\alpha_c(n)$:\n$$\n\\alpha_c(n) = n \\left((n-1)^{-1/n}\\right)^{n+1} = n (n-1)^{-(n+1)/n}\n$$\nThis expression can be written in a more clear form:\n$$\n\\alpha_c(n) = \\frac{n}{(n-1)^{(n+1)/n}} = \\frac{n}{(n-1)^{1+1/n}}\n$$\n\nJustification of Biological Relevance:\nThe critical value $\\alpha_c(n)$ is a threshold that separates two distinct dynamical regimes. For $\\alpha < \\alpha_c(n)$, the system is monostable, with a single stable state where epithelial and mesenchymal markers are co-expressed. This corresponds to a plastic, intermediate phenotype. For $\\alpha > \\alpha_c(n)$, the system becomes bistable. The symmetric state becomes unstable, and two new stable states emerge: a high-$x$, low-$y$ (epithelial) state and a low-$x$, high-$y$ (mesenchymal) state.\nIn the context of carcinoma, cells can undergo EMT, a process pathologically reactivated during metastasis. The parameter $\\alpha$ represents the effective synthesis rate of the regulatory factors. Factors in the tumor microenvironment or oncogenic mutations can increase the production of transcription factors, thereby increasing the effective value of $\\alpha$. When this parameter is driven across the critical threshold $\\alpha_c(n)$, the underlying cellular regulatory network gains the capacity for a stable phenotypic switch. The overexpression of a specific EMT-TF (the mesenchymal determinant $y$) acts as a directional bias or perturbation that pushes the cell from the basin of the epithelial state into the newly available basin of attraction for the mesenchymal state. The double-negative feedback then locks the cell in this aggressive, migratory phenotype. Therefore, crossing the stability boundary $\\alpha_c(n)$ is the fundamental event that enables the stable acquisition of mesenchymal traits by carcinoma cells.", "answer": "$$\n\\boxed{\\frac{n}{(n-1)^{1 + \\frac{1}{n}}}}\n$$", "id": "2623008"}, {"introduction": "Tumor growth relies on the population dynamics of a hierarchy of cells. This exercise models a Cancer Stem Cell (CSC) hierarchy, where CSCs self-renew with probability $p$ and progenitors undergo a limited number of divisions. By setting up and solving a system of linear ODEs, you will derive the asymptotic fraction of CSCs in a growing tumor, revealing how fundamental parameters like $p$ and the division rates $\\lambda_s$ and $\\lambda_p$ control tumor composition [@problem_id:2622958].", "problem": "A tissue maintained by developmental hierarchies is modeled with a cancer stem cell (CSC) compartment and a progenitor compartmental cascade. Cancer Stem Cells (CSCs) divide at a constant per-cell rate $\\lambda_s$ in continuous time. Each CSC division is symmetric and results in either two CSCs with probability $p$ (symmetric self-renewal) or two progenitors with probability $1-p$ (symmetric differentiation). Newly produced progenitors enter the top progenitor compartment with $k$ remaining divisions. Progenitors divide symmetrically at a constant per-cell rate $\\lambda_p$; a progenitor with $i \\in \\{1,\\dots,k\\}$ remaining divisions produces two progenitors with $i-1$ remaining divisions. After the last progenitor division ($i=1$), daughters are terminal and exit the cycling pool. There is no death within the cycling compartments, no asymmetric divisions, and no de-differentiation. Assume $p > \\tfrac{1}{2}$ so that the CSC population sustains exponential growth and the system approaches an asymptotic steady composition.\n\nStarting from first principles of continuous-time birth processes and linear mass-action flow between compartments, and without invoking any pre-packaged results, derive the asymptotic equilibrium fraction of CSCs among all cycling cells (that is, CSCs plus progenitors with $1 \\le i \\le k$) in the long-time limit. Express your final answer as a single closed-form analytic expression in terms of $p$, $\\lambda_s$, $\\lambda_p$, and $k$. No numerical evaluation or rounding is required.", "solution": "The problem statement will first be subjected to rigorous validation.\n\n**Step 1: Extract Givens**\n- Cell populations: Cancer Stem Cells (CSCs) and a progenitor cascade with $k$ compartments.\n- CSC division rate: A constant per-cell rate $\\lambda_s$.\n- CSC division outcomes: Symmetric, producing two CSCs with probability $p$ or two progenitors with probability $1-p$.\n- Progenitor production: New progenitors enter the top compartment with $k$ remaining divisions.\n- Progenitor division rate: A constant per-cell rate $\\lambda_p$.\n- Progenitor division outcome: Symmetric; a progenitor with $i$ divisions remaining produces two progenitors with $i-1$ divisions remaining, for $i \\in \\{1, \\dots, k\\}$.\n- Terminal cells: After the last progenitor division ($i=1$), daughters are terminal and exit the cycling pool.\n- Model constraints: No cell death in cycling compartments, no asymmetric divisions, no de-differentiation.\n- System dynamics constraint: $p > \\frac{1}{2}$, ensuring exponential growth of the CSC population.\n- Objective: Derive the asymptotic equilibrium fraction of CSCs among all cycling cells (CSCs + progenitors with $1 \\le i \\le k$) in the long-time limit, as a closed-form analytic expression in terms of $p$, $\\lambda_s$, $\\lambda_p$, and $k$.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem describes a compartmental model of a cell hierarchy, which is a standard and well-established framework in mathematical biology for studying tissue dynamics and cancer. The assumptions, while simplifications (e.g., no cell death), are common for creating analytically tractable models. The model is scientifically sound within its defined scope.\n- **Well-Posed**: The condition $p > \\frac{1}{2}$ ensures the CSC population grows exponentially, driving the entire system. In such a system of coupled linear ordinary differential equations, the populations of all compartments are expected to grow at the same exponential rate in the long-time limit. This leads to a stable asymptotic composition, meaning the fraction of any one cell type approaches a constant value. A unique and meaningful solution is therefore expected to exist.\n- **Objective**: The problem is formulated with precise, quantitative, and unambiguous language.\n- **Completeness and Consistency**: The model's rules for division, differentiation, and compartment flow are fully specified. The parameters are defined, and the objective is clear. There are no internal contradictions.\n\n**Step 3: Verdict and Action**\nThe problem is valid. It is a well-posed, scientifically grounded problem in theoretical biology that can be solved using standard mathematical methods. We proceed with the solution.\n\nLet $N_s(t)$ be the number of CSCs at time $t$, and let $N_i(t)$ be the number of progenitor cells with $i$ divisions remaining, for $i \\in \\{1, \\dots, k\\}$. The dynamics of these populations are described by a system of first-order linear ordinary differential equations.\n\nThe rate of change of the CSC population, $\\frac{dN_s}{dt}$, is determined by the net effect of CSC divisions. A division occurs at rate $\\lambda_s N_s(t)$. With probability $p$, this division is a symmetric self-renewal, increasing the CSC count by one ($2$ daughters $- 1$ parent). With probability $1-p$, it is a symmetric differentiation, decreasing the CSC count by one ($-1$ parent). The expected change per division is thus $p(+1) + (1-p)(-1) = 2p - 1$.\n$$ \\frac{dN_s}{dt} = \\lambda_s (2p - 1) N_s(t) $$\nSince $p > \\frac{1}{2}$, the growth rate $\\Lambda \\equiv \\lambda_s (2p - 1)$ is positive, and the CSC population grows exponentially: $N_s(t) = N_s(0) \\exp(\\Lambda t)$.\n\nThe progenitor compartments are populated by CSC differentiation and subsequent progenitor divisions.\nThe top progenitor compartment, $N_k$, receives an influx of $2$ cells for every symmetric differentiation event of a CSC. These events occur at a rate of $\\lambda_s N_s(t) (1-p)$. Cells in this compartment are lost through their own division at a rate of $\\lambda_p N_k(t)$.\n$$ \\frac{dN_k}{dt} = 2 \\lambda_s (1-p) N_s(t) - \\lambda_p N_k(t) $$\nFor any intermediate progenitor compartment $N_i$ with $i \\in \\{1, \\dots, k-1\\}$, the influx comes from the division of cells in the compartment above, $N_{i+1}$. Each division of a cell in $N_{i+1}$ produces two cells in $N_i$. The outflux is due to the division of cells within the $N_i$ compartment itself.\n$$ \\frac{dN_i}{dt} = 2 \\lambda_p N_{i+1}(t) - \\lambda_p N_i(t) \\quad \\text{for } i \\in \\{1, \\dots, k-1\\} $$\nAs the CSC population drives the entire system with an exponential growth rate $\\Lambda$, all progenitor populations will asymptotically grow at the same rate. We can thus posit a long-time solution of the form $N_s(t) = C_s \\exp(\\Lambda t)$ and $N_i(t) = C_i \\exp(\\Lambda t)$ for $i \\in \\{1, \\dots, k\\}$, where $C_s$ and $C_i$ are constants representing the relative sizes of the compartments in the stable asymptotic state.\n\nSubstituting this ansatz into the system of differential equations and dividing by the common factor $\\exp(\\Lambda t)$ yields a system of algebraic equations for the coefficients:\nFrom the equation for $N_k(t)$:\n$$ \\Lambda C_k = 2 \\lambda_s (1-p) C_s - \\lambda_p C_k \\implies C_k (\\Lambda + \\lambda_p) = 2 \\lambda_s (1-p) C_s $$\n$$ \\frac{C_k}{C_s} = \\frac{2 \\lambda_s (1-p)}{\\Lambda + \\lambda_p} $$\nFrom the equations for $N_i(t)$, $i \\in \\{1, \\dots, k-1\\}$:\n$$ \\Lambda C_i = 2 \\lambda_p C_{i+1} - \\lambda_p C_i \\implies C_i (\\Lambda + \\lambda_p) = 2 \\lambda_p C_{i+1} $$\nThis gives a recurrence relation for the progenitor coefficients:\n$$ \\frac{C_i}{C_{i+1}} = \\frac{2 \\lambda_p}{\\Lambda + \\lambda_p}, \\quad \\text{for } i \\in \\{1, \\dots, k-1\\} $$\nLet $r = \\frac{2 \\lambda_p}{\\Lambda + \\lambda_p}$. This is a constant ratio. We can express each $C_i$ in terms of $C_k$:\n$C_{k-1} = r C_k$, $C_{k-2} = r C_{k-1} = r^2 C_k$, and in general, $C_i = r^{k-i} C_k$.\n\nThe objective is the asymptotic fraction of CSCs, $F_{CSC}$, among all cycling cells.\n$$ F_{CSC} = \\lim_{t \\to \\infty} \\frac{N_s(t)}{N_s(t) + \\sum_{i=1}^k N_i(t)} = \\frac{C_s}{C_s + \\sum_{i=1}^k C_i} = \\frac{1}{1 + \\frac{\\sum_{i=1}^k C_i}{C_s}} $$\nLet $C_P = \\sum_{i=1}^k C_i$ be the sum of progenitor coefficients.\n$$ C_P = \\sum_{i=1}^k r^{k-i} C_k = C_k \\sum_{j=0}^{k-1} r^j $$\nThis is a finite geometric series. Assuming $r \\neq 1$, the sum is $\\frac{r^k - 1}{r - 1}$.\nThe case $r=1$ corresponds to $\\Lambda = \\lambda_p$. Our final formula will be valid for this case by taking the limit.\n$$ C_P = C_k \\frac{r^k - 1}{r - 1} $$\nNow we express the ratio $\\frac{C_P}{C_s}$ in terms of the model parameters.\n$$ \\frac{C_P}{C_s} = \\frac{C_k}{C_s} \\left(\\frac{r^k - 1}{r - 1}\\right) = \\left(\\frac{2 \\lambda_s (1-p)}{\\Lambda + \\lambda_p}\\right) \\left(\\frac{r^k - 1}{r - 1}\\right) $$\nWe can simplify the term with $r-1$:\n$$ r - 1 = \\frac{2 \\lambda_p}{\\Lambda + \\lambda_p} - 1 = \\frac{2 \\lambda_p - (\\Lambda + \\lambda_p)}{\\Lambda + \\lambda_p} = \\frac{\\lambda_p - \\Lambda}{\\Lambda + \\lambda_p} $$\nSubstituting this into the expression for $\\frac{C_P}{C_s}$:\n$$ \\frac{C_P}{C_s} = \\left(\\frac{2 \\lambda_s (1-p)}{\\Lambda + \\lambda_p}\\right) \\left(\\frac{r^k - 1}{\\frac{\\lambda_p - \\Lambda}{\\Lambda + \\lambda_p}}\\right) = \\frac{2 \\lambda_s (1-p)}{\\lambda_p - \\Lambda} (r^k - 1) $$\nNow, we find $F_{CSC}$:\n$$ F_{CSC}^{-1} = 1 + \\frac{C_P}{C_s} = 1 + \\frac{2 \\lambda_s (1-p)}{\\lambda_p - \\Lambda} (r^k - 1) = \\frac{(\\lambda_p - \\Lambda) + 2 \\lambda_s (1-p) (r^k - 1)}{\\lambda_p - \\Lambda} $$\nLet us simplify the numerator:\n$$ (\\lambda_p - \\Lambda) - 2 \\lambda_s (1-p) + 2 \\lambda_s (1-p) r^k = \\lambda_p - (\\Lambda + 2 \\lambda_s (1-p)) + 2 \\lambda_s (1-p) r^k $$\nThe term $\\Lambda + 2\\lambda_s(1-p)$ simplifies to $\\lambda_s(2p-1) + 2\\lambda_s - 2\\lambda_s p = \\lambda_s$.\nSo, the numerator becomes $\\lambda_p - \\lambda_s + 2 \\lambda_s (1-p) r^k$.\n$$ F_{CSC}^{-1} = \\frac{\\lambda_p - \\lambda_s + 2 \\lambda_s (1-p) r^k}{\\lambda_p - \\Lambda} $$\nInverting this expression gives $F_{CSC}$:\n$$ F_{CSC} = \\frac{\\lambda_p - \\Lambda}{\\lambda_p - \\lambda_s + 2 \\lambda_s (1-p) r^k} $$\nFinally, we substitute $\\Lambda = \\lambda_s(2p-1)$ and $r = \\frac{2 \\lambda_p}{\\Lambda + \\lambda_p} = \\frac{2 \\lambda_p}{\\lambda_s(2p-1) + \\lambda_p}$ to obtain the final expression in terms of the given parameters.\n$$ F_{CSC} = \\frac{\\lambda_p - \\lambda_s(2p-1)}{\\lambda_p - \\lambda_s + 2 \\lambda_s (1-p) \\left( \\frac{2\\lambda_p}{\\lambda_p+\\lambda_s(2p-1)} \\right)^k} $$\nThis expression represents the asymptotic fraction of cancer stem cells in the entire cycling population.", "answer": "$$ \\boxed{ \\frac{\\lambda_p - \\lambda_s(2p-1)}{\\lambda_p - \\lambda_s + 2\\lambda_s(1-p) \\left(\\frac{2\\lambda_p}{\\lambda_p + \\lambda_s(2p-1)}\\right)^k} } $$", "id": "2622958"}]}